TJ101
NSCLC, HNSCC, advanced solid tumors
Phase 1Active
Key Facts
About Phrontline Biopharma
A Chinese biotech developing innovative bispecific dual-payload ADCs to deliver next-generation frontline cancer therapies.
View full company profileNSCLC, HNSCC, advanced solid tumors
A Chinese biotech developing innovative bispecific dual-payload ADCs to deliver next-generation frontline cancer therapies.
View full company profile